Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Anal Sci ; 40(8): 1397-1407, 2024 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-38649628

RESUMEN

Analyzing new psychoactive substances (NPSs) in forensic laboratories present a formidable challenge globally. Within illicit drug analysis, gas chromatography-mass spectrometry (GC-MS) emerges as a robust analytical tool. This study endeavors to assess and compare peak resolution in the analysis of illicit drugs, specifically focusing on 21 synthetic cathinones, encompassing 9 cathinone isomers. Varied GC-MS operating conditions, including distinct GC-MS columns and thermal gradients, were systematically employed for the simultaneous analysis of these synthetic cathinones. The study utilized HP-1 nonpolar and HP-5MS low-bleed columns to achieve optimal analyte resolution through modulation of GC-MS oven conditions. Mass spectra were meticulously recorded within a mass-to-charge (m/z) range spanning from 40 to 500 in full scan mode. The data showed that the cathinone isomers slightly differed in retention times and mass spectra. The GC oven conditions affected the peak resolution for chromatographic separation even with the same column. The peak resolution improved using a slower thermal gradient heat speed with a prolonged analysis time. Conclusively, the interplay of GC columns and thermal gradients emerged as pivotal factors impacting peak resolution in the analysis of illicit drugs. These empirical insights contribute to a nuanced understanding of peak resolution dynamics and facilitate the identification of synthetic cathinones, including their isomers, in seized materials through the judicious application of GC-MS methodologies.

2.
Int J Anal Chem ; 2023: 9895595, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-37492520

RESUMEN

Knowing the stability of drugs is important to ensure accurate and reliable results of drug concentrations. This study evaluated the stability of ten new psychoactive substances (NPSs) in urine and methanol/water at different storage temperatures. Quantitative analyses were performed using liquid chromatography-tandem mass spectrometry. Three replicates of each storage condition were analyzed at day 0 and after 7, 14-, 30-, 60-, and 90 days with storage at +25°C, +4°C, and -20°C. For each analyte, the percent difference at each time interval from day 0 was calculated for each storage condition. Para-methoxyamphetamine (PMA), para-methoxymethamphetamine (PMMA), deschloroketamine (DCK), and 2-fluorodeschloroketamine (2-FDCK) were stable in urine, even when stored for 90-day periods at various temperatures. For synthetic cathinones, the concentrations declined over time at room temperature (+25°C) in urine but were relatively stable in methanol solvent with 0.1% formic acid. The significant degradation was found at +25°C, and the most excellent stability was shown by samples stored at -20°C. Phenethylamines (PMA and PMMA) and ketamine substitutes (DCK and 2-FDCK) were relatively more stable than synthetic cathinones (mephedrone, butylone, pentylone, ephylone, 4-MEAPP, and eutylone).

3.
Sports Biomech ; : 1-15, 2023 Jan 17.
Artículo en Inglés | MEDLINE | ID: mdl-36650711

RESUMEN

The objective was to determine the reliability and validity of a local positioning system (LPS) promising high accuracy at reduced product costs. Fifty-five random static positions in a gym (54.8 × 26.0 m) were obtained 10 times via LPS (50 Hz) and measuring tape. An athlete's LPS-derived peak and time-series speed and acceleration during dynamic movements (n = 80) were compared with Vicon (100 Hz). Reliability and validity were assessed via Intraclass and Concordance Correlation Coefficients (ICC/CCC), root mean square errors, Bland-Altman plots, and analysis of variance. ICC3,1 (≥0.999) and CCC (0.387-0.999) were calculated for static positions (errors <0.22 m). CCC for time-series speed and acceleration, and peak speed, acceleration, and deceleration were 0.884-0.902, 0.777-0.854, 0.923, 0.486, and 0.731, respectively. Errors were larger in time-series acceleration (14.37 ± 3.77%) than in speed (11.99 ± 5.78%) (ηp2 = 0.472, p < 0.001) and in peak acceleration (28.04 ± 14.34%) and deceleration (25.07 ± 14.90%) than in speed (7.34 ± 6.07%) (ηp2 = 0.091, p < 0.01). LPS achieved excellent reliability and moderate-to-excellent validity of time-series speed and acceleration. The system accurately measured peak speed but not peak acceleration and deceleration. The system is suitable for analyses based on instantaneous speed and acceleration in game sports (e.g., energy estimations).

4.
Mar Drugs ; 18(8)2020 Jul 23.
Artículo en Inglés | MEDLINE | ID: mdl-32718084

RESUMEN

13-Acetoxysarcocrassolide (13-AC), a marine cytotoxic product isolated from the alcyonacean coral Lobophytum crassum, exhibited potent antitumor and immunostimulant effects as reported in previous studies. However, the 13-AC antitumor mechanism of action against oral cancer cells remains unclear. The activity of 13-AC against Ca9-22 cancer cells was determined using MTT assay, flow cytometric analysis, immunofluorescence, immunoprecipitation, Western blotting, and siRNA. 13-AC induced apoptosis in oral cancer cells Ca9-22 through the disruption of mitochondrial membrane potential (MMP) and the stimulation of reactive oxygen species (ROS) generation. It increased the expression of apoptosis- and DNA damage-related proteins in a concentration- and time-dependent manner. It exerted potent antitumor effect against oral cancer cells, as demonstrated by the in vivo xenograft animal model. It significantly reduced the tumor volume (55.29%) and tumor weight (90.33%). The pretreatment of Ca9-22 cells with N-acetylcysteine (NAC) inhibited ROS production resulting in the attenuation of the cytotoxic activity of 13-AC. The induction of the Keap1-Nrf2 pathway and the promotion of p62/SQSTM1 were observed in Ca9-22 cells treated with 13-AC. The knockdown of p62 expression by siRNA transfection significantly attenuated the effect of 13-AC on the inhibition of cell viability. Our results indicate that 13-AC exerted its cytotoxic activity through the promotion of ROS generation and the suppression of the antioxidant enzyme activity. The apoptotic effect of 13-AC was found to be mediated through the interruption of the Keap1/Nrf2/p62/SQSTM1 pathway, suggesting its potential future application as an anticancer agent.


Asunto(s)
Antineoplásicos/farmacología , Diterpenos/farmacología , Proteína 1 Asociada A ECH Tipo Kelch/metabolismo , Neoplasias de la Boca/tratamiento farmacológico , Factor 2 Relacionado con NF-E2/metabolismo , Proteína Sequestosoma-1/metabolismo , Animales , Apoptosis/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Células HCT116 , Células HeLa , Humanos , Células MCF-7 , Masculino , Potencial de la Membrana Mitocondrial/efectos de los fármacos , Ratones Desnudos , Neoplasias de la Boca/enzimología , Neoplasias de la Boca/genética , Neoplasias de la Boca/patología , Especies Reactivas de Oxígeno/metabolismo , Proteína Sequestosoma-1/genética , Transducción de Señal , Carga Tumoral/efectos de los fármacos , Ensayos Antitumor por Modelo de Xenoinjerto
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...